Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

The biopharma reported disappointing fourth-quarter results, missing bottom line estimates amid a steep decline in COVID-19 ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

Robert F Kennedy Jr has been approved by the Senate and sworn in by President Donald Trump as head of the US Department of Health and Human Services.12 After being sworn in on 13 February, Kennedy, ...

Robert F. Kennedy Jr. was confirmed Thursday as President Trump’s health secretary amidst several ethics and disinformation ...

Moderna Inc.'s stock fell 2.9% early Friday, after the biotech posted a wider-than-expected fourth-quarter loss and offered soft guidance for 2025, offsetting a revenue beat.

Happy V-Day! Gorge on heart-shaped chocolate and ponder the implications of RFK Jr. being sworn in as health secretary. Today, we talk about that, as well as new cancer data from Corbus Pharma, Europe ...

The Senate on Thursday confirmed Robert F. Kennedy Jr. as President Donald Trump’s health secretary, putting the ...

Cassidy was begging for the simplest possible concession from the man President Trump had chosen to serve as the nation’s top ...